Replies to post #685246 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Notsure2 - Exactly, hence the motivation behind the comments "people are dying..." Lack of empathy is part of bureaucratic culture.

Click on: "NICE's response to comment of the draft scope and provisional matrix"

Read the first row, to the right:

Comment noted. NICE
aims to publish
guidance on cancer
drugs within 90 days of
marketing authorisation.
Any requirements for
potential delays will be
taken into account as
appropriate.

[dstock07734]

Do you have commonsense? GBM is one of the most life-threatening diseases, if not the most one. Now in UK, the occurrence rate is two or three times higher than it used to be. Each month probably plenty GBM patients filed for compassionate use program and you are talking about NICE reimbursement in 90 days.

See this consultation survey with DCVax-L included? It ends on January 26, 2024. Most likely NICE has the payment scheme setup immediately after the MHRA approval.

The consultation runs until midnight at the end of 26 January 2024.

https://www.england.nhs.uk/publication/amendments-2023-25-nhs-payment-scheme/